Compare DSX & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSX | EMBC |
|---|---|---|
| Founded | 1999 | 1924 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.1M | 354.1M |
| IPO Year | 2005 | 2021 |
| Metric | DSX | EMBC |
|---|---|---|
| Price | $2.36 | $6.37 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 777.1K | ★ 800.4K |
| Earning Date | 11-23-2026 | 11-24-2026 |
| Dividend Yield | ★ 1.71% | 0.65% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $8.68 | $5.59 |
| P/E Ratio | $16.02 | ★ $6.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.64 | $2.77 |
| 52 Week High | $3.20 | $14.91 |
| Indicator | DSX | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 29.88 | 53.64 |
| Support Level | $2.30 | $3.01 |
| Resistance Level | $2.61 | $6.90 |
| Average True Range (ATR) | 0.08 | 0.33 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 17.19 | 52.23 |
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.